Back to Search
SHEILA KAR, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1922143007IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
A52841(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1982
Research & Publications (20)
Exploring the roles of noise in the eukaryotic cell cycle.
PMID 19246388·Proc Natl Acad Sci U S A·2009
8-other
Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
PMID 19197936·Eur J Immunol·2009
7-preclinical
Overlapping double turn conformations adopted by tetrapeptides containing non-coded alpha-amino isobutyric acid (Aib) and formation of tape-like structures through supramolecular helix mediated self-assembly.
PMID 19508219·Protein Pept Lett·2009
8-other
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
PMID 18246350·Cancer Chemother Pharmacol·2008
7-preclinical
An evaluation of musculoskeletal disorder and socioeconomic status of farmers in West Bangal, India.
PMID 18298013·Nepal Med Coll J·2007
8-other
alpha-Thrombin inhibits DNA synthesis in rat hepatocytes but not in hepatoma cells by receptor activation and proteolysis.
PMID 17516031·Mol Cell Biochem·2007
7-preclinical
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
PMID 16969075·Cancer Biol Ther·2006
7-preclinical
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
PMID 16930563·Biochem Pharmacol·2006
7-preclinical
PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
PMID 16818510·Mol Cancer Ther·2006
7-preclinical
Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
PMID 16399207·Neurobiol Aging·2006
4-observational
Nucleoid remodeling by an altered HU protein: reorganization of the transcription program.
PMID 16258062·Proc Natl Acad Sci U S A·2005
8-other
Sustained simultaneous glycolytic and insulin oscillations in beta-cells.
PMID 15935387·J Theor Biol·2005
7-preclinical
Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound.
PMID 15319298·Carcinogenesis·2004
4-observational
Autoionizing 1Se resonance of H- in Debye plasma environments.
PMID 15697518·Phys Rev E Stat Nonlin Soft Matter Phys·2004
8-other
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
PMID 15644984·J Psychiatry Neurosci·2004
6-review
Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology.
PMID 14650921·Prog Brain Res·2004
6-review
Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
PMID 12950176·Biochemistry·2003
8-other
Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor.
PMID 12663499·Carcinogenesis·2003
7-preclinical
Discodermolide interferes with the binding of tau protein to microtubules.
PMID 12650922·FEBS Lett·2003
7-preclinical
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol.
PMID 12505985·EMBO J·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 N ROBERTSON BLVD, 115
BEVERLY HILLS, CA 90211 - Phone
- (310) 657-8500
Quick Facts
- NPI
- 1922143007
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile